Mobile Site ›
Normal View

Test ID: FNEA
Neurokinin A (Substance K)

Secondary ID A test code used for billing and in test definitions created prior to November 2011

57115

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

No

Method Name A short description of the method used to perform the test

Radioimmunoassay

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Neurokinin A

Aliases Lists additional common names for a test, as an aid in searching

Neurokinin A FORWARD
Substance K

Specimen Type Describes the specimen type needed for testing

GI Plasma

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Collect blood in special tube containing G.I. Preservative (MML

supply number T669).   Spin down and send 4 mL of EDTA

plasma in plastic vial, freeze immediately.

 

NOTE:  Patient should not be on any antacid medication or

medications that affect hypertension, gastroentero intestinal

functions, or pain relievers, if possible, for at least 48 hours prior

to collection.

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

3 mL

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Specimens other than

Plasma

Anticoagulants other than

EDTA with special GI preservative (MML supply T669)

Hemolysis

NA

Thawing

Warm reject; Cold reject

Lipemia

NA

Icteric

NA

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
GI PlasmaFrozen28 days

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

<40 pg/mL

 

Test Performed By:  Cambridge Biomedical Inc.

                                       1320 Soldiers Field Road

                                        Boston, MA  02135

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Every other Tuesday

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

1-14 days

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

3-17 days

Performing Laboratory Location The location of the laboratory that performs the test

Cambridge Biomedical Inc.

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.

The performance characteristics of the listed assay was validated by Cambridge Biomedical Inc. The US FDA has not approved or cleared this test. The results of this assay can be used for clinical diagnosis without FDA approval. Cambridge Biomedical Inc. is a CLIA certified, CAP accredited laboratory for performing high complexity assays such as this one.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

83519

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
Z2259Neurokinin A49728-9